Fonar MRI patent trial is postponed

Article

The judge hearing patent litigationbetween MRI manufacturer Fonar and competitors GE and Hitachihas postponed a trial date for the case. The litigation, in whichFonar is suing GE, Hitachi and two imaging centers for violatingits basic MRI patents, was

The judge hearing patent litigationbetween MRI manufacturer Fonar and competitors GE and Hitachihas postponed a trial date for the case. The litigation, in whichFonar is suing GE, Hitachi and two imaging centers for violatingits basic MRI patents, was scheduled to go to trial Dec. 5 inU.S. District Court for Eastern New York in Hauppauge, NY. Fonaris claiming damages of $362 million from the defendants (SCAN11/23/94).

The judge delayed the start of the trial because the litigantshave not yet agreed on the appointment of an independent expertwho will instruct the judge and jury in the basics of MRI technology,according to Fonar counsel Ronald Schutz of Robins, Kaplan, Millerand Ciresi in Minneapolis. A new date has not been set for thetrial, although Schutz believes it should begin in the next severalmonths.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.